Personalized Cancer Medicine Market, Global Outlook and Forecast 2023-2028

Report ID: 1372455 | Published Date: Jan 2025 | No. of Page: 63 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Personalized Cancer Medicine Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Personalized Cancer Medicine Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Personalized Cancer Medicine Overall Market Size
    2.1 Global Personalized Cancer Medicine Market Size: 2021 VS 2028
    2.2 Global Personalized Cancer Medicine Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Personalized Cancer Medicine Players in Global Market
    3.2 Top Global Personalized Cancer Medicine Companies Ranked by Revenue
    3.3 Global Personalized Cancer Medicine Revenue by Companies
    3.4 Top 3 and Top 5 Personalized Cancer Medicine Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Personalized Cancer Medicine Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Personalized Cancer Medicine Players in Global Market
        3.6.1 List of Global Tier 1 Personalized Cancer Medicine Companies
        3.6.2 List of Global Tier 2 and Tier 3 Personalized Cancer Medicine Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Personalized Cancer Medicine Market Size Markets, 2021 & 2028
        4.1.2 Monoclonal Antibodies
        4.1.3 Personalized Cancer Vaccines
        4.1.4 Other
    4.2 By Type - Global Personalized Cancer Medicine Revenue & Forecasts
        4.2.1 By Type - Global Personalized Cancer Medicine Revenue, 2017-2022
        4.2.2 By Type - Global Personalized Cancer Medicine Revenue, 2023-2028
        4.2.3 By Type - Global Personalized Cancer Medicine Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Personalized Cancer Medicine Market Size, 2021 & 2028
        5.1.2 Breast Cancer
        5.1.3 Lung Cancer
        5.1.4 Chronic Myeloid Leukaemia
        5.1.5 Bowel Cancer
        5.1.6 Other Cancer
    5.2 By Application - Global Personalized Cancer Medicine Revenue & Forecasts
        5.2.1 By Application - Global Personalized Cancer Medicine Revenue, 2017-2022
        5.2.2 By Application - Global Personalized Cancer Medicine Revenue, 2023-2028
        5.2.3 By Application - Global Personalized Cancer Medicine Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Personalized Cancer Medicine Market Size, 2021 & 2028
    6.2 By Region - Global Personalized Cancer Medicine Revenue & Forecasts
        6.2.1 By Region - Global Personalized Cancer Medicine Revenue, 2017-2022
        6.2.2 By Region - Global Personalized Cancer Medicine Revenue, 2023-2028
        6.2.3 By Region - Global Personalized Cancer Medicine Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Personalized Cancer Medicine Revenue, 2017-2028
        6.3.2 US Personalized Cancer Medicine Market Size, 2017-2028
        6.3.3 Canada Personalized Cancer Medicine Market Size, 2017-2028
        6.3.4 Mexico Personalized Cancer Medicine Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Personalized Cancer Medicine Revenue, 2017-2028
        6.4.2 Germany Personalized Cancer Medicine Market Size, 2017-2028
        6.4.3 France Personalized Cancer Medicine Market Size, 2017-2028
        6.4.4 U.K. Personalized Cancer Medicine Market Size, 2017-2028
        6.4.5 Italy Personalized Cancer Medicine Market Size, 2017-2028
        6.4.6 Russia Personalized Cancer Medicine Market Size, 2017-2028
        6.4.7 Nordic Countries Personalized Cancer Medicine Market Size, 2017-2028
        6.4.8 Benelux Personalized Cancer Medicine Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Personalized Cancer Medicine Revenue, 2017-2028
        6.5.2 China Personalized Cancer Medicine Market Size, 2017-2028
        6.5.3 Japan Personalized Cancer Medicine Market Size, 2017-2028
        6.5.4 South Korea Personalized Cancer Medicine Market Size, 2017-2028
        6.5.5 Southeast Asia Personalized Cancer Medicine Market Size, 2017-2028
        6.5.6 India Personalized Cancer Medicine Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Personalized Cancer Medicine Revenue, 2017-2028
        6.6.2 Brazil Personalized Cancer Medicine Market Size, 2017-2028
        6.6.3 Argentina Personalized Cancer Medicine Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Personalized Cancer Medicine Revenue, 2017-2028
        6.7.2 Turkey Personalized Cancer Medicine Market Size, 2017-2028
        6.7.3 Israel Personalized Cancer Medicine Market Size, 2017-2028
        6.7.4 Saudi Arabia Personalized Cancer Medicine Market Size, 2017-2028
        6.7.5 UAE Personalized Cancer Medicine Market Size, 2017-2028
7 Players Profiles
    7.1 Abbott
        7.1.1 Abbott Corporate Summary
        7.1.2 Abbott Business Overview
        7.1.3 Abbott Personalized Cancer Medicine Major Product Offerings
        7.1.4 Abbott Personalized Cancer Medicine Revenue in Global Market (2017-2022)
        7.1.5 Abbott Key News
    7.2 Merck
        7.2.1 Merck Corporate Summary
        7.2.2 Merck Business Overview
        7.2.3 Merck Personalized Cancer Medicine Major Product Offerings
        7.2.4 Merck Personalized Cancer Medicine Revenue in Global Market (2017-2022)
        7.2.5 Merck Key News
    7.3 Novartis
        7.3.1 Novartis Corporate Summary
        7.3.2 Novartis Business Overview
        7.3.3 Novartis Personalized Cancer Medicine Major Product Offerings
        7.3.4 Novartis Personalized Cancer Medicine Revenue in Global Market (2017-2022)
        7.3.5 Novartis Key News
    7.4 Amgen
        7.4.1 Amgen Corporate Summary
        7.4.2 Amgen Business Overview
        7.4.3 Amgen Personalized Cancer Medicine Major Product Offerings
        7.4.4 Amgen Personalized Cancer Medicine Revenue in Global Market (2017-2022)
        7.4.5 Amgen Key News
    7.5 Celgene
        7.5.1 Celgene Corporate Summary
        7.5.2 Celgene Business Overview
        7.5.3 Celgene Personalized Cancer Medicine Major Product Offerings
        7.5.4 Celgene Personalized Cancer Medicine Revenue in Global Market (2017-2022)
        7.5.5 Celgene Key News
    7.6 Bayer
        7.6.1 Bayer Corporate Summary
        7.6.2 Bayer Business Overview
        7.6.3 Bayer Personalized Cancer Medicine Major Product Offerings
        7.6.4 Bayer Personalized Cancer Medicine Revenue in Global Market (2017-2022)
        7.6.5 Bayer Key News
    7.7 Roche
        7.7.1 Roche Corporate Summary
        7.7.2 Roche Business Overview
        7.7.3 Roche Personalized Cancer Medicine Major Product Offerings
        7.7.4 Roche Personalized Cancer Medicine Revenue in Global Market (2017-2022)
        7.7.5 Roche Key News
    7.8 Astellas
        7.8.1 Astellas Corporate Summary
        7.8.2 Astellas Business Overview
        7.8.3 Astellas Personalized Cancer Medicine Major Product Offerings
        7.8.4 Astellas Personalized Cancer Medicine Revenue in Global Market (2017-2022)
        7.8.5 Astellas Key News
    7.9 Astrazeneca
        7.9.1 Astrazeneca Corporate Summary
        7.9.2 Astrazeneca Business Overview
        7.9.3 Astrazeneca Personalized Cancer Medicine Major Product Offerings
        7.9.4 Astrazeneca Personalized Cancer Medicine Revenue in Global Market (2017-2022)
        7.9.5 Astrazeneca Key News
    7.10 Johnson & Johnson
        7.10.1 Johnson & Johnson Corporate Summary
        7.10.2 Johnson & Johnson Business Overview
        7.10.3 Johnson & Johnson Personalized Cancer Medicine Major Product Offerings
        7.10.4 Johnson & Johnson Personalized Cancer Medicine Revenue in Global Market (2017-2022)
        7.10.5 Johnson & Johnson Key News
    7.11 Agilent
        7.11.1 Agilent Corporate Summary
        7.11.2 Agilent Business Overview
        7.11.3 Agilent Personalized Cancer Medicine Major Product Offerings
        7.11.4 Agilent Personalized Cancer Medicine Revenue in Global Market (2017-2022)
        7.11.5 Agilent Key News
    7.12 Takeda
        7.12.1 Takeda Corporate Summary
        7.12.2 Takeda Business Overview
        7.12.3 Takeda Personalized Cancer Medicine Major Product Offerings
        7.12.4 Takeda Personalized Cancer Medicine Revenue in Global Market (2017-2022)
        7.12.5 Takeda Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Personalized Cancer Medicine Market Opportunities & Trends in Global Market
    Table 2. Personalized Cancer Medicine Market Drivers in Global Market
    Table 3. Personalized Cancer Medicine Market Restraints in Global Market
    Table 4. Key Players of Personalized Cancer Medicine in Global Market
    Table 5. Top Personalized Cancer Medicine Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Personalized Cancer Medicine Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Personalized Cancer Medicine Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Personalized Cancer Medicine Product Type
    Table 9. List of Global Tier 1 Personalized Cancer Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Personalized Cancer Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Personalized Cancer Medicine Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Personalized Cancer Medicine Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Personalized Cancer Medicine Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Personalized Cancer Medicine Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Personalized Cancer Medicine Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Personalized Cancer Medicine Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Personalized Cancer Medicine Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Personalized Cancer Medicine Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Personalized Cancer Medicine Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Personalized Cancer Medicine Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Personalized Cancer Medicine Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Personalized Cancer Medicine Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Personalized Cancer Medicine Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Personalized Cancer Medicine Revenue, (US$, Mn), 2023-2028
    Table 30. Abbott Corporate Summary
    Table 31. Abbott Personalized Cancer Medicine Product Offerings
    Table 32. Abbott Personalized Cancer Medicine Revenue (US$, Mn), (2017-2022)
    Table 33. Merck Corporate Summary
    Table 34. Merck Personalized Cancer Medicine Product Offerings
    Table 35. Merck Personalized Cancer Medicine Revenue (US$, Mn), (2017-2022)
    Table 36. Novartis Corporate Summary
    Table 37. Novartis Personalized Cancer Medicine Product Offerings
    Table 38. Novartis Personalized Cancer Medicine Revenue (US$, Mn), (2017-2022)
    Table 39. Amgen Corporate Summary
    Table 40. Amgen Personalized Cancer Medicine Product Offerings
    Table 41. Amgen Personalized Cancer Medicine Revenue (US$, Mn), (2017-2022)
    Table 42. Celgene Corporate Summary
    Table 43. Celgene Personalized Cancer Medicine Product Offerings
    Table 44. Celgene Personalized Cancer Medicine Revenue (US$, Mn), (2017-2022)
    Table 45. Bayer Corporate Summary
    Table 46. Bayer Personalized Cancer Medicine Product Offerings
    Table 47. Bayer Personalized Cancer Medicine Revenue (US$, Mn), (2017-2022)
    Table 48. Roche Corporate Summary
    Table 49. Roche Personalized Cancer Medicine Product Offerings
    Table 50. Roche Personalized Cancer Medicine Revenue (US$, Mn), (2017-2022)
    Table 51. Astellas Corporate Summary
    Table 52. Astellas Personalized Cancer Medicine Product Offerings
    Table 53. Astellas Personalized Cancer Medicine Revenue (US$, Mn), (2017-2022)
    Table 54. Astrazeneca Corporate Summary
    Table 55. Astrazeneca Personalized Cancer Medicine Product Offerings
    Table 56. Astrazeneca Personalized Cancer Medicine Revenue (US$, Mn), (2017-2022)
    Table 57. Johnson & Johnson Corporate Summary
    Table 58. Johnson & Johnson Personalized Cancer Medicine Product Offerings
    Table 59. Johnson & Johnson Personalized Cancer Medicine Revenue (US$, Mn), (2017-2022)
    Table 60. Agilent Corporate Summary
    Table 61. Agilent Personalized Cancer Medicine Product Offerings
    Table 62. Agilent Personalized Cancer Medicine Revenue (US$, Mn), (2017-2022)
    Table 63. Takeda Corporate Summary
    Table 64. Takeda Personalized Cancer Medicine Product Offerings
    Table 65. Takeda Personalized Cancer Medicine Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Personalized Cancer Medicine Segment by Type in 2021
    Figure 2. Personalized Cancer Medicine Segment by Application in 2021
    Figure 3. Global Personalized Cancer Medicine Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Personalized Cancer Medicine Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Personalized Cancer Medicine Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Personalized Cancer Medicine Revenue in 2021
    Figure 8. By Type - Global Personalized Cancer Medicine Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Personalized Cancer Medicine Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Personalized Cancer Medicine Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Personalized Cancer Medicine Revenue Market Share, 2017-2028
    Figure 12. US Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Personalized Cancer Medicine Revenue Market Share, 2017-2028
    Figure 16. Germany Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
    Figure 17. France Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Personalized Cancer Medicine Revenue Market Share, 2017-2028
    Figure 24. China Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
    Figure 28. India Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Personalized Cancer Medicine Revenue Market Share, 2017-2028
    Figure 30. Brazil Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Personalized Cancer Medicine Revenue Market Share, 2017-2028
    Figure 33. Turkey Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
    Figure 37. Abbott Personalized Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Merck Personalized Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Novartis Personalized Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Amgen Personalized Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Celgene Personalized Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Bayer Personalized Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Roche Personalized Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Astellas Personalized Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Astrazeneca Personalized Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Johnson & Johnson Personalized Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Agilent Personalized Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Takeda Personalized Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
63
Frequently Asked Questions
Personalized Cancer Medicine Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Personalized Cancer Medicine Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Personalized Cancer Medicine Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports